Abstract | PURPOSE: EXPERIMENTAL DESIGN: Cytotoxicity in vitro was evaluated using 10 human tumor cell lines. SiHa cells were used to characterize metabolism under hypoxia, by liquid chromatography-mass spectrometry, and DNA damage by comet assay and gammaH2AX formation. Antitumor activity was evaluated in multiple xenograft models (PR-104 +/- radiation or chemotherapy) by clonogenic assay 18 h after treatment or by tumor growth delay. RESULTS: The phosphate ester "pre- prodrug" PR-104 was well tolerated in mice and converted rapidly to the corresponding prodrug PR-104A. The cytotoxicity of PR-104A was increased 10- to 100-fold by hypoxia in vitro. Reduction to the major intracellular metabolite, hydroxylamine PR-104H, resulted in DNA cross-linking selectively under hypoxia. Reaction of PR-104H with chloride ion gave lipophilic cytotoxic metabolites potentially able to provide bystander effects. In tumor excision assays, PR-104 provided greater killing of hypoxic (radioresistant) and aerobic cells in xenografts (HT29, SiHa, and H460) than tirapazamine or conventional mustards at equivalent host toxicity. PR-104 showed single-agent activity in six of eight xenograft models and greater than additive antitumor activity in combination with drugs likely to spare hypoxic cells ( gemcitabine with Panc-01 pancreatic tumors and docetaxel with 22RV1 prostate tumors). CONCLUSIONS:
|
Authors | Adam V Patterson, Dianne M Ferry, Shelley J Edmunds, Yongchuan Gu, Rachelle S Singleton, Kashyap Patel, Susan M Pullen, Kevin O Hicks, Sophie P Syddall, Graham J Atwell, Shangjin Yang, William A Denny, William R Wilson |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 13
Issue 13
Pg. 3922-32
(Jul 01 2007)
ISSN: 1078-0432 [Print] United States |
PMID | 17606726
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Cross-Linking Reagents
- Histones
- Nitrogen Mustard Compounds
- PR-104
- Phosphates
- gamma-H2AX protein, mouse
- DNA
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Cell Line, Tumor
- Comet Assay
- Cross-Linking Reagents
(pharmacology)
- DNA
(chemistry)
- DNA Damage
- Drug Screening Assays, Antitumor
- Histones
(metabolism)
- Humans
- Hypoxia
- Mice
- Neoplasm Transplantation
- Neoplasms
(drug therapy)
- Nitrogen Mustard Compounds
(chemistry, pharmacology)
- Phosphates
(pharmacology)
|